Sonia Ioannidis

Sonia Ioannidis is an accomplished clinical scientist with extensive experience in hematology-oncology and immuno-oncology clinical development. Currently serving as Executive Director at Incyte since 2023, Sonia has held various roles at the same company since 2017, including Senior Director and Director. Prior to Incyte, Sonia contributed to drug development and partnerships for rare and orphan diseases at Dorphan SA. At Debiopharm International SA, Sonia held multiple positions, culminating as Head of Immune-mediated Diseases, overseeing evaluations in immunology and oncology. Academic foundations include a PhD from the Ludwig Institute for Cancer Research, complemented by a Master's in Biochemistry and Immunology and a Bachelor's in Biology from the University of Lausanne.